-
According to officials with Barr Laboratories, makers of Seasonale, studies should begin by the end of the year.
CNN: Emerging contraceptive options
-
Even firms that produce generic drugs such as Barr Laboratories (nyse: BRL - news - people ) are getting involved with Accenture's test program.
FORBES: Tiny Chips Could Combat Counterfeit Pills
-
The antidepressant's patent runs out on Aug. 2, at which point you can bet generic drugmaker Barr Laboratories (nyse: BRL - news - people) of Pomona, N.
FORBES: Eli Lilly's Flowers Of The Mind
-
But a year ago, generic drugmaker Barr Laboratories (nyse: BRL - news - people ) won a court case allowing it to make a copycat version of Prozac earlier than expected.
FORBES: FDA Gives Conditional Approval To Lilly's Xigris
-
Goldstein expects that even if the courts slow things down, Barr Laboratories (nyse: BRL - news - people ) will start selling a cheaper generic version of Prozac come September at the latest.
FORBES: Eli Lilly Faces Fate
-
According to Stephen Rosenfeld, a lawyer with the Prescription Access Litigation Project, which has launched a class-action suit against AstraZeneca and Barr Laboratories over Tamoxifen, an anti-cancer drug, delays to generic drugs mean that 42m Americans who lack health insurance pay a high price, and may not get essential medicines at all.
ECONOMIST: Prescription drugs
-
While oral contraceptives have a good safety record (and Barr Laboratories' trial of 1, 400 women showed no evidence that Seasonale is riskier than conventional contraceptive pills, except for a higher incidence of irregular bleeding in the first few months of use), Dr Hitchcock is keen to see women exercise caution when it comes to prolonged use of anything containing sex hormones.
ECONOMIST: Controlling menstruation
-
Within healthcare, Perry is bullish on generic-drug makers like Eon Labs (nasdaq: ELAB - news - people ), Barr Laboratories (nyse: BRL - news - people ), Teva Pharmaceutical (nasdaq: TEVA - news - people ), Lannett (nyse: LCI - news - people ) and Perrigo (nasdaq: PRGO - news - people ).
FORBES: Magazine Article